Better Therapeutics, Inc. operates as a digital therapeutics company, which engages in developing a novel form of cognitive behavioral therapy to address the root causes of cardio metabolic diseases. It offers software-based solutions for type 2 diabetes, heart disease and other conditions. The company was founded by Kevin J. Appelbaum and David P. Perry in April 2015 and is headquartered in San Francisco, CA.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Better Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Better Therapeutics Inc market cap is $5,400.00.
What is the 52-week high for Better Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Better Therapeutics Inc 52 week high is $0.001 as of October 14, 2025.
What is the 52-week low for Better Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Better Therapeutics Inc 52 week low is $0.00 as of October 14, 2025.
What is Better Therapeutics Inc stock price today?
Better Therapeutics Inc stock price today is $0.0001.
What was Better Therapeutics Inc stock price yesterday?
Better Therapeutics Inc stock price yesterday was $0.0001.
What is the 50-day moving average of Better Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Better Therapeutics Inc 50-day moving average is $0.0001.